Suppr超能文献

Tc964,一种新型抗原蛋白的分子特征研究。

Molecular Characterization of Tc964, A Novel Antigenic Protein from .

机构信息

Grupo de Investigación en Enfermedades Infecciosas, Departamento de Microbiología, Facultad de Ciencias, Pontificia Universidad Javeriana, Carrera 7 # 40- 62, Bogotá, Colombia.

Grupo de Investigación en Inmunotoxicología, Departamento de Farmacia, Facultad de Ciencias, Universidad Nacional de Colombia, Carrera 30 # 45-01, Bogota, Colombia.

出版信息

Int J Mol Sci. 2020 Mar 31;21(7):2432. doi: 10.3390/ijms21072432.

Abstract

The Tc964 protein was initially identified by its presence in the interactome associated with the LYT1 mRNAs, which code for a virulence factor of . Tc964 is annotated in the genome as a hypothetical protein. According to phylogenetic analysis, the protein is conserved in the different genera of the Trypanosomatidae family; however, recognizable orthologues were not identified in other groups of organisms. Therefore, as a first step, an in-depth molecular characterization of the Tc946 protein was carried out. Based on structural predictions and molecular dynamics studies, the Tc964 protein would belong to a particular class of GTPases. Subcellular fractionation analysis indicated that Tc964 is a nucleocytoplasmic protein. Additionally, the protein was expressed as a recombinant protein in order to analyze its antigenicity with sera from Chagas disease (CD) patients. Tc964 was found to be antigenic, and B-cell epitopes were mapped by the use of synthetic peptides. In parallel, the homologue (Lm964) was also expressed as recombinant protein and used for a preliminary evaluation of antigen cross-reactivity in CD patients. Interestingly, Tc964 was recognized by sera from Chronic CD (CCD) patients at different stages of disease severity, but no reactivity against this protein was observed when sera from Colombian patients with cutaneous leishmaniasis were analyzed. Therefore, Tc964 would be adequate for CD diagnosis in areas where both infections (CD and leishmaniasis) coexist, even though additional assays using larger collections of sera are needed in order to confirm its usefulness for differential serodiagnosis.

摘要

Tc964 蛋白最初是通过其在与 LYT1 mRNA 相互作用组中的存在而被鉴定的,LYT1 mRNA 编码一种 的毒力因子。Tc964 在 基因组中被注释为一种假定蛋白。根据系统发育分析,该蛋白在不同的锥虫科属中是保守的;然而,在其他生物群体中没有识别到可识别的同源物。因此,作为第一步,对 Tc946 蛋白进行了深入的分子特征分析。基于结构预测和分子动力学研究,Tc964 蛋白属于一种特殊的 GTPase 类。亚细胞分级分析表明,Tc964 是一种核质蛋白。此外,为了分析其与恰加斯病(CD)患者血清的抗原性,该蛋白被表达为重组蛋白。结果发现 Tc964 具有抗原性,并通过使用合成肽来绘制 B 细胞表位。同时,也表达了 同源物(Lm964)作为重组蛋白,用于初步评估 CD 患者中的抗原交叉反应性。有趣的是,Tc964 被处于不同疾病严重程度阶段的慢性 CD(CCD)患者的血清所识别,但当分析来自患有皮肤利什曼病的哥伦比亚患者的血清时,没有观察到针对该蛋白的反应性。因此,Tc964 可用于存在这两种感染(CD 和利什曼病)的地区的 CD 诊断,尽管需要使用更大的血清样本集进行额外的检测,以确认其用于差异血清学诊断的有用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1941/7177413/a4ccf01c310f/ijms-21-02432-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验